Doximity (DOCS)
(Delayed Data from NYSE)
$57.33 USD
-1.42 (-2.42%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $57.33 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
DOCS 57.33 -1.42(-2.42%)
Will DOCS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for DOCS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DOCS
Teladoc Health Q2 Loss Narrower Than Expected on Declining Expenses
Hims & Hers Leads the Charge in AI-Powered Personalized Healthcare
DOCS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Doximity (DOCS) Reports Next Week: Wall Street Expects Earnings Growth
Does OptimizeRx Have a Moat in the Crowded HealthTech Space?
OMCL vs. DOCS: Which Stock Is the Better Value Option?
Other News for DOCS
New Doximity Study Shows Modest Physician Pay Growth Amid Deeper Workforce Strain, ...
Doximity Inc (DOCS) Releases 2025 Physician Compensation Report Highlighting Workforce ...
Fidelity Mid-Cap Stock Fund Q2 2025 Commentary
Doximity: Slowing Sales And EBITDA Growth
Doximity (DOCS) Price Target Raised by Truist Securities | DOCS Stock News